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Summary
Synthetic chemists often exploit the high enantiose-
lectivity of lipases to prepare pure enantiomers of pri-
mary alcohols, but the molecular basis for this enan-
tioselectivity is unknown. The crystal structures of
two phosphonate transition-state analogs bound to
Burkholderia cepacia lipase reveal this molecular ba-
sis for a typical primary alcohol: 2-methyl-3-phenyl-
1-propanol. The enantiomeric alcohol moieties adopt
surprisingly similar orientations, with only subtle dif-
ferences that make it difficult to predict how to alter
enantioselectivity. These structures, along with a sur-
vey of previous structures of enzyme bound enantio-
mers, reveal that binding of enantiomers does not in-
volve an exchange of two substituent positions as
most researchers assumed. Instead, the enantiomers
adopt mirror-image packing, where three of the four
substituents at the stereocenter lie in similar posi-
tions. The fourth substituent, hydrogen, points in op-
posite directions.
Introduction
Molecular recognition, especially enantiomer recogni-
tion, is a key to the biological specificity of many cur-
rent drugs. Enantiopure compounds for pharmaceutical
intermediates and other uses is currently a rapidly
growing multibillion business worldwide [1]. Under-
standing enantiomer recognition is key to both under-
standing the mechanism of action of these drugs and
to designing good synthetic routes to enantiopure com-
pounds. Unfortunately, our understanding of enanti-
omer recognition is still primitive and most drug design*Correspondence: rjk@umn.edu
3 Present address: Biotechnology Research Institute, National Re-
search Council of Canada, 6100 Royalmount Avenue, Montréal,
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Korea.
5 Current address: Department of Biochemistry, Molecular Biology,
and Biophysics and The Biotechnology Institute, University of Min-
nesota, 1479 Gortner Avenue, St. Paul, Minnesota 55108.and synthesis design rely on trial and error. In this pa-
per, we identify the molecular basis of enantiomer re-
cognition of a lipase toward an unnatural substrate.
Lipases show moderate to high enantioselectivity to-
ward a wide range of primary and secondary alcohols,
making them useful catalysts for the preparation of
these important building blocks for chiral drugs. For ex-
ample, a primary alcohol, (R)- and (S)-2-methyl-3-phe-
nyl-1-propanol ([MPP], Figure 1A), is a precursor for
fungicidal compounds [2], adenosine receptor agonists
and antagonists [3], and a cholesterol biosynthesis
inhibitor [4]. Although many lipases show high enantio-
selectivity toward secondary alcohols, only a few—Burk-
holderia cepacia lipase (BCL, formerly called Pseudo-
monas cepacia lipase), porcine pancreatic lipase, and
Achromobacter sp. lipase—also show high enantio-
selectivity toward primary alcohols [5, 6]. The molecular
basis for this enantioselectivity toward primary alcohols
is uncertain. Understanding it would allow rational de-
sign of substrates (substrate engineering), reaction
conditions (medium engineering), and enzyme (protein
engineering) for higher enantioselectivity.
Lipases are serine hydrolases and lipase-catalyzed
ester hydrolysis involves two successive tetrahedral in-
termediates. The first tetrahedral intermediate, Td1, re-
leases the alcohol and forms the acyl enzyme (Figure
1B), while the second tetrahedral intermediate, Td2, re-
leases the acid. Only Td1 includes the alcohol moiety
and therefore only Td1 contributes to enantioselectivity
(E) of lipases toward chiral alcohols.
Previous molecular modeling of this tetrahedral inter-
mediate [7, 8], a similar one [9], or phosphonate analogs
in the active site of BCL suggested several possible ori-
gins of enantioselectivity toward primary alcohols. The
modeling focused on the hydrolysis of the acetate or
butanoate ester of a typical primary alcohol, 2-methyl-
3-phenyl-1-propanol (MPP) [7, 8]. Two research groups
suggested that the relative orientation of the enantio-
mers involves an exchange of positions of the methyl
and hydrogen substituents (Figure 2). However, the ori-
entation of the primary alcohol moiety and the pro-
posed explanation for enantioselectivity differed. Tuomi
and Kazlauskas [7] suggested that enantioselectivity
stems from a better binding of the fast-reacting enanti-
omer. Zuegg et al. [9] proposed a similar explanation
for 2-phenyl-1-butanol, a similar primary alcohol con-
taining one more CH2 group. However, Tomic´ et al. [8]
suggested that enantioselectivity stems from a shorter
key hydrogen bond between the catalytic serine and
histidine.
Here we report an experimental approach to identify
the origin of enantioselectivity using X-ray crystal struc-
tures of transition state analogs bound to BCL. These
structures contain the same alcohol moiety as the mod-
eling above, but different acyl groups. The modeling
used the acetate or butanoate esters, while the X-ray
structures mimic reaction of the heptanoate ester. The
relative orientations of the enantiomers in these struc-
tures differ significantly from the modeling.
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428Figure 1. Phosphonates Mimic the Transition State in the BCL-Catalyzed Resolution of MPP Esters
On the left, from the top: (A) BCL catalyzed hydrolysis of racemic MPP-ester yields (R)-MPP-ester and (S)-MPP. (B) The first tetrahedral
intermediate Td1 releases alcohol (ROH) to form an acyl enzyme in the BCL-catalyzed hydrolysis of esters. The formation and/or breakdown
of this tetrahedral intermediate determines the enantioselectivity of BCL toward alcohols. The phosphonate analog mimics Td1. On the right,
from the top: BCL-inactivator complexes. (C) BCL-1-(R), (D) BCL-1-(S), (E) overlay of BCL-1-(R) and BCL-1-(S). In (C), (D), and (E), catalytic
triad residues His286 and Ser87, oxyanion hole residues Glu88 and Leu17, nearby residues Thr18, Tyr29, and Leu287 and phosphonate esters
are in stick representation.
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429Figure 2. Enantiomer Recognition by Enzymes Relies on Interac-
tions between the Substituents at the Stereocenter and the Rec-
ognition Site
For the fast-reacting enantiomer all four interactions match. For the
slow-reacting enantiomer, only two substituents match when all the
substituents point to the interaction sites. (Exchanging substitu-
ents H and B of the fast enantiomer creates the slow enantiomer.)
However, if one substituent of the slow enantiomer does not in-
teract with any of the four sites, then the three remaining substitu-
ents match. (An umbrella-like inversion of the fast enantiomer ste-
reocenter along the C–H bond creates slow enantiomer). X-ray
crystal structures of enantiomeric configuration bound to enzyme
suggest the second mechanism is the most common one.Results
Synthesis of Phosphonate Esters
and Inhibition of BCL
A straightforward modification of published procedures
[10, 11] yielded two phosphonate p-nitrophenyl esters
that contain as alcohol moieties pure enantiomers
of (R)-MPP or (S)-MPP (Table 1). While phosphonyl
chlorides containing secondary alcohol moieties are
relatively stable [10, 11], these phosphonyl chlorides
contained primary alcohols and were not stable. We
therefore replaced the chloride leaving group with the
less reactive p-nitrophenol. Nucleophilic displacement
of one chloride of hexylphosphonic dichloride by one
equivalent of chiral alcohol yielded a mono-substituted
phosphonyl chloride, which was converted in situ to the
desired p-nitrophenyl derivative by treatment with two
equivalents of p-nitrophenol in the presence of di-iso-
propyl ethylamine. Each reaction formed an equimolar
mixture of (SP) and (RP) epimers due to the phospho-
rous stereocentre (31P NMR showed two resonances
for the phosphorous atom (see Experimental Proce-
dures). We did not attempt to separate the epimers.
Inactivation of BCL with 1000-fold excess of either
1-(R) or 1-(S) irreversibly inhibited more than 98% of the
hydrolytic activity of BCL toward p-nitrophenol acetate.
The solvent for the inactivation of BCL was 50 vol%
n-propanol in aqueous buffer because the BCL-inacti-
vator complexes precipitated from buffer containing
less than 50 vol% n-propanol.
Crystal Structure of BCL-Inactivator Complexes
We crystallized the BCL-inactivator complexes by the
hanging drop method using a reservoir containing 25%n-propanol in imidazole buffer 50 mM (pH 6.5). We esti-
mate that the crystals formed at a concentration of
n-propanol of about 30%. The crystals of the inhibited
complexes were isomorphous with the crystals of the
open form of BCL previously reported (PDB ID 3LIP
[12]). Similarly, the X-ray structures of the complexes
show no significant differences in the polypeptide
backbone or in the side chain conformations compared
with the open conformation of BCL. The root mean
squared deviation (rmsd) in Cα positions between the
open form of BCL and the BCL-1-(R) and BCL-1-(S)
complexes are 0.41 Å and 0.39 Å, respectively. Data
collection and refinement statistics (Table 1) show that
the structures are of high quality with resolutions of
1.10 and 1.50 Å.
Both phosphonate esters bind similarly to BCL (Fig-
ures 1C–1E). Both covalently link the phosphorous
to Oγ of catalytic Ser87 and have RP configuration.
Nucleophilic attack at phosphorus by Oγ of the cata-
lytic serine likely proceeds with inversion of configura-
tion at phosphorus [13]; thus, the favored epimer had
SP configuration prior to the reaction. The hexyl chain
of the phosphonate esters extends into the hydropho-
bic groove HA (Figures 1C–1E). Lang et al. [14] reported
similar acyl chain orientation for a triacylglycerol analog
bound to BCL. In both BCL-1-(R) and BCL-1-(S), the
phosphonate esters fold into a hairpin with similar dis-
tances between the hexyl chain and the benzylic CH2
(4.9 Å in BCL-1-(R) and 5.3 Å in BCL-1-(S)). All distances
refer to heavy atom to heavy atom distances (e.g., be-
tween carbons of two methylene groups) unless speci-
fied otherwise. The superimposed structures show that
the alcohol oxygen OI, the medium substituent (CH3),
and the large substituent (PhCH2) all lie in a similar po-
sition in BCL-1-(R) and in BCL-1-(S). The alcohol oxy-
gens OI differ by only 0.3 Å. Surprisingly, the large
substituents (PhCH2) lie in a solvent-exposed crevice
(Figures 1C–1E) and are not bound to hydrophobic re-
gions of the substrate binding site. Since three substit-
uents at the stereocenter are in similar positions, the
fourth hydrogen must differ to account for the enantio-
meric configurations at the carbon stereocenter. Indeed
the hydrogen substituents of the two structures point
in opposite directions. Thus, the alcohol portions of
BCL-1-(R) and BCL-1-(S) adopt a mirror-image orienta-
tion, Figure 2.
Both inactivators mimic a catalytically productive ori-
entation because they contain all the five hydrogen
bonds necessary for catalysis (Table 2). The phospho-
nyl oxygen in the oxyanion hole is hydrogen bonded to
the NH of Leu17 and Glu88 (2.73 Å and 2.81 Å in BCL-
1-(R); 2.73 Å and 2.82 Å in BCL-1-(S)). The catalytic
Ser87 Oγ is hydrogen bonded to His286 N2 (3.05 Å,
116° in BCL-1-(R); 3.02 Å, 115° in BCL-1-(S)). These hy-
drogen bond angles are slightly more acute than the
180°–120° expected for a hydrogen bond. The catalytic
Asp264 Oδ2 is at hydrogen bonding distance from
His286 Nδ2 (2.81 Å in BCL-1-(R); 2.82 Å in BCL-1-(S)).
The oxygen OI of the alcohol moiety forms a similar
hydrogen bond with His286 N2 in both structures
(3.30 Å, 126° in BCL-1-(R); 3.17 Å, 132° in BCL-1-(S)).
Both inactivators have a gauche+ conformation be-
tween the Ser87 Oγ-P bond and the OI-CH2 bond of the
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430Table 1. Data Collection Statistics and Refinement Parameters
BCL-1-(R) BCL-1-(S)
Phosphonate Inactivators
Data statistics
Resolution range (Å) 44.4–1.10 37.8–1.50
Highest resolution shell (Å) 1.14–1.10 1.55–1.50
Space group C2 C2
Unit cell dimensions
a (Å) 88.8 88.9
b (Å) 46.2 46.2
c (Å) 84.6 84.7
(°) 90 90
β (°) 121.3 121.3
γ (°) 90 90
Mosaicity (°) 0.22 0.27
R merge (%) 4.1 (10.6) 4.3 (12.7)
Completeness of the data (%) 89.2 (40.8) 90.3 (53.5)
No. of observations 495813 152333
No. of unique reflections 105990 42707
Mean I/σI 21.0 (4.6) 19.0 (5.4)
Refinement statistics
Total non-hydrogen atoms 2498 2498
Protein atoms 2331 2331
No. of waters 147 147
No. of calcium ions 1 1
Final R factor (%)a 16.0 16.7
Final R free (%)b 17.2 18.1
Rms deviations from ideality for
Bond lengths (Å) 0.008 0.014
Bond angles (°) 1.38 1.47
Mean B factors (Å2)
Protein 8.47 9.01
Solvent 13.15 13.89
Calcium ion 6.39 6.66
Inactivator 12.17 10.42
a R factor = ΣFc − Fo/ΣFo × 100 where Fc and Fo are the calculated and observed structure factor amplitudes.
b 5% of the total reflections were randomly selected and used to calculate R free.alcohol moiety (dihedral angle Ser87Oγ-P-OI-CH2 of 72° B
(in BCL-1-(R) and of 77° in BCL-1-(S)). In the true tetra-
hedral intermediate, this orientation may promote re- S
dlease of Ser87 Oγ and the return to the starting esters
due to overlap between the lone pair of the alcohol oxy- d
agen and the s* orbital of the Oγ-P bond [15]. Since both
transition state analogs adopt this orientation, it cannot t
contribute to the enantioselectivity.
The most striking difference is the position of the hy- B
pdrogen, which points in opposite directions in the two
enantiomers. Neither orientation makes significant in- c
4teractions with the enzyme. In BCL-1-(S) the hydrogen
at the stereocenter is at 3.68 Å from His298 Cδ2 while b
ein BCL-1-(R) it is at 3.25 Å from Leu17 carbonyl oxygen
(Table 2). M
vThe CH2(1)-OI substituent orientation differs little in
the two structures. As mentioned above, the hydrogen c
Mbond to His286 N2 is nearly identical. Other, barely sig-
nificant differences are that CH2(1) in BCL-1-(S) is C
lslightly closer to Leu17 carbonyl (3.50 Å versus 3.60 Å)
and to His86 C1 (4.24 Å versus 4.41 Å) (Table 2). t
The benzylic CH2(3) shows only subtle differences in
the two structures (Table 2). For the faster reacting 0CL-1-(S) it lies close to the carbonyl oxygen of Leu17
3.52 Å). This interaction may be unfavorable because
chultz et al. [16] suggested that atoms other than hy-
rogen cause repulsion when directed toward this resi-
ue. For the slow (R)-enantiomer, CH2(3) is close to cat-
lytic His286 (4.07 Å to N2, 3.77 Å to Cδ2, and 3.87 Å
o Cγ of His286), which may also cause steric strain.
The phenyl shows a more favorable interaction with
CL for the fast-reacting (S)-enantiomer (Table 2). The
henyl ring of (S)-MPP is slightly closer to the side
hain methyl groups of Leu287 (mean distance of
.43 Å in (S)-MPP versus 4.72 in (R)-MPP), suggesting
etter hydrophobic interaction for the fast-reacting (S)-
nantiomer. On the other hand the phenyl ring of (R)-
PP is closer to Cγ1 of Thr18 (mean distance of 5.17 Å
ersus 5.42 Å), but this distance is too long for a signifi-
ant interaction. The phenyl ring of slow-reacting (R)-
PP shows two different orientations (dihedral angle
H3-C*-CH2-Ph 48° versus 70°) suggesting that it binds
ess tightly than (S)-MPP, which shows only one orien-
ation.
The methyl substituent shows similar positions (only
.63 Å apart) in BCL-1-(S) and BCL-1-(R). One interac-
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431Table 2. Key Hydrogen Bond Distances (Heavy Atom to Heavy Atom) and Key Angles in the Two BCL-Inactivator Complexes and Summary
of Subtle Interactions Alcohol Moiety-Enzyme Residues that May Contribute to the Enantioselectivity in the Complexes BCL-Inactivator
Key Hydrogen Bond Distances BCL-1-(R) BCL-1-(S)
Leu17 N(H)–O=P, Åa 2.73 2.73
Gln88 N(H)–O=P, Åa 2.81 2.82
Nδ2 His286–Oδ2 Asp264, Å 2.81 2.82
N2 His286–Oγ Ser87, Å 3.05 3.02
His286 N2–H–Oγ Ser87 θ, ° 116 115
N2 His286–OIb, Å 3.30 3.17
His286 N2–H–OIb, θ, ° 126 132
Ser87Oγ–P–OI–CH2, θ, ° 72 77
Interactions BCL-1-(R) BCL-1-(S)
Benzyl substituent
Leu287 s.c.c–Ph mean 4.72 Å mean 4.43 Å
Thr18 Cγ1–Ph mean 5.17 Å mean 5.42 Å
His286 s.c.c–CH2(3) 4.07 Å to N2 —d
3.77 Å to Cδ2 —d
3.87 Å to Cγ —d
Leu17 C=O–CH2(3) —d 3.52 Å
CH2(1)-OI substituent
Leu17 C=O–CH2(1) 3.60 Å 3.50 Å
His286 N2–OI 3.30 Å, 126° 3.17 Å, 132°
His86 s.c.–CH2(1) 4.41 Å to C1 4.24 Å to C1
5.36 Å to N2 5.23 Å to N2
4.64 Å to Nδ1 4.41 Å to Nδ1
Hydrogen substituent
Leu17 C=O–CH(2) 3.25 Å —d
His286 Cδ2–CH(2) —d 3.68 Å
Methyl substituent
Thr 18 Cγ1–CH3(4) 4.81 Å 5.37 Å
Thr 18 Oγ1–CH3(4) 3.79 Å 4.06 Å
Leu17 C=O–CH3(4) 3.37 Å 3.62 Å
Tyr29OH–CH3(4) 4.11 Å 3.62 Å
His86 s.c.–CH3(4) 4.85 Å to C1 4.32 Å to C1
6.03 Å to N2 5.54 Å to N2
5.19 Å to Nδ1 4.61 Å to Nδ1
a The angles N-H-O range from 164° to 166°, which is typical of hydrogen bonds.
b OI is the MPP alcohol oxygen.
c s.c. = side chain.
d —, too far away for significant interaction.tion is more crowded for the fast-reacting enantiomer.
The methyl substituent of BCL-1-(S) lies 3.62 Å from
Tyr29 OH, while in BCL-1-(R) it is 4.11 Å away. Two
other interactions are more crowded for the slow-react-
ing enantiomer. The methyl substituent of BCL-1-(R)
lies 3.79 Å from Oγ1 of Thr18, while in BCL-1-(S) it is
4.06 Å away. The methyl substituent of BCL-1-(R) lies
3.37 Å from the carbonyl oxygen of Leu17, while in
BCL-1-(S) it is 3.62 Å away.
Enantioselectivity and Kinetic Constants
BCL shows high enantioselectivity (E R 190) favoring
the (S)-enantiomer in the hydrolysis of MPP-heptanoate
(MPP-C ) in a solvent similar to that used for crystalliza-7tion of the BCL-inactivator complexes (Table 3) [17]. (To
avoid possible chemical hydrolysis during the enantio-
selectivity measurement, we replaced the imidazole
buffer used for the crystallization of the complexes with
phosphate buffer.) The kinetic constants for each
enantiomer, determined spectrophotometrically, show
similar KM values for the two enantiomers (3 mM for
(R)-MPP-C7 and 4 mM for (S)-MPP-C7), but 100-fold dif-
ferent kcat values (kcat = 0.4 min−1 for (S)-MPP-C7 and
0.004 min−1 for (R)-MPP-C7) (Table 3). The solubility
limit of MPP-heptanoate was approximately equal to
KM, resulting in large standard errors in the measured
kcat and KM values (estimated to be ±25%). Despite this
uncertainty, the kinetic constants show that the enan-
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432Table 3. Kinetic Constants for (R) and (S)-MPP-C7
(R)-MPP-C7 (S)-MPP-C7
kcat (min−1) 0.004 ± 0.001 0.4 ± 0.1
KM (mM) 3 ± 1 4 ± 1
(kcat/KM) (1.3 ± 0.6)10−3 0.10 ± 0.04
Ea [(kcat/KM(S))/(kcat/KM(R))] 80 ± 50
End point Eb >190 ± 30
Conditions for determination of kinetic constants: [BES] = 7.44 mM, [PNP] = 1.24 mM, [BCL] = 2.85 g/ml, [(R) and (S)-MPP-C7] = 0.6 to 4.5
mM, [n-propanol] = 28.8%. Data were analyzed by Eadie-Hofstee plots [27, 28]
a Calculated from the kcat and KM values. This value agrees with the end point E determination within the error limits, providing a check on
the determination of the KM and kcat values.
b Determined by GC analysis of reaction products and starting materials at 39% conversion according to Chen et al. [29]. The measured
enantiomeric purity of the remaining starting material was 63% ee, while the measured enantiomeric purity of the product was > 98%.tioselectivity of BCL toward these substrates stems c
sfrom the higher kcat value with (S)-MPP-C7. Nishizawa
et al. [18] reached a similar conclusion from their mea- m
isured kinetic constants for BCL-catalyzed hydrolysis of
similar esters.
l
pDiscussion
These X-ray crystal structures of transition state ana-
logs bound to BCL first show that primary and second-
ary alcohols bind differently to this lipase. The compari-
son of the X-ray structure of BCL complexed with a
phosphonate containing a secondary alcohol moiety
((R)-1-phenoxy-2-butanol) [19] with that of BCL-1-(S)
shows a major difference in the position of the large
substituent (Figure 3). The phenoxy group of the se-
condary alcohol binds in a large hydrophobic pocket
(HA pocket), which also binds the acyl moiety of the
phosphonates. In contrast, the benzyl group of the pri-
mary alcohols points toward the solvent. This binding
difference explains why different rules are needed for
the enantiopreference of BCL toward primary and to-
ward secondary alcohols [7–9, 20].
The enantiomeric MPP moieties show mirror-image
packing. These primary alcohol moieties are flexible
since they contain two rotatable bonds between the al-
cohol oxygen and the stereocenter. However, this flexi-
bility is unlikely to be the only reason for the mirror-
image orientation because less flexible moieties also
show mirror-image packing. For example, the menthol
moiety of CRL-menthol complexes also shows mirror-
image packing [10] (Table 4). This secondary alcohol F
contains only one rotatable bond between the alcohol i
oxygen and the stereocenter and a six-membered ring, O
(but still shows mirror-image packing. One possible
creason for the mirror-image packing is that it allows
hthree substituents to bind in nearly the same position
l(one mismatch), while exchanging two substituents
p
causes two mismatches, Figure 2. In contrast, molecu- p
lar modeling always suggests an exchange of two sub- H
astituents, likely because it mimics the behavior of me-acking is the most common way that enantiomers ori-
igure 3. Different Binding of Primary and Secondary Alcohols
n BCL
verlap of stick representations of the BCL complex with O-(2R)-
1-phenoxy-2-butyl)-methylphosphonyl ([19], [PDB ID 1HQD], cpk
olors) with the complex BCL-1-(S) (blue). For the secondary alco-
ol, the large substituent at the stereocenter (phenoxy) binds in a
arge hydrophobic pocket (upper portion of figure), while for the
rimary alcohol, the large substituent at the stereocenter (benzyl)
oints toward the solvent (center of figure). Catalytic triad residues
is286 and Ser87, oxyanion hole residue Leu17, residues Thr18
nd Tyr29, and inactivators are also in stick representation.hanical models and it is easier to understand. These
tructures emphasize that modeling enantioselectivity
ust consider mirror-image packing as a way of mak-
ng mistakes.
A survey of X-ray crystal structures of enantiomeric
igands bound to enzymes shows that mirror-image
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433Table 4. Examples of X-Ray Crystal Structures Containing Bound Enantiomeric Ligands
Enzyme Ligand Mirror-Image Orientation PDB Code Reference
Alanine racemase yes, H inverted [30]
1L6F, 1L6G
Human retinoic acid yes, H inverted 1EXA, 1EXX [31]
receptor
Carboxypeptidase A yes, H inverted 1HDQ, 1HEE [32]
γ-Chymotrypsyn yes, H inverted 1VGC, 2VGC [33]
γ-Chymotrypsyn yes, H inverted 3VGC, 4VGC [33]
Subtilisin Carlsberg yes, H inverted 1VSB, 1AVT [33]
Subtilisin Carlsberg yes, H inverted 1AV7, 3VSB [33]
Human serum albumin yes, H inverted 1H9Z, 1HA2 [34]
Human methionine yes, H inverted 1KQ0, 1KQ9 [35]
aminoipeptidase Type II
Herpes simplex type 1 yes, H inverted 1E2Ia [36]
thymidine kinase
(continued)
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434Table 4. Continued
Enzyme Ligand Mirror-Image Orientation PDB Code Reference
Horse Liver Alcohol yes, H inverted 1BTO, 3BTO [37]
Dehydrogenase
Candida rugosa lipase yes, H inverted 1LPM, 1LPS [10]
Isocitrate dehydrogenase yes, H inverted 1PB1, 1P8F [38]
Citrate synthase yes, H inverted 3CSC, 4CSC [39]
Inositol monophosphatase yes, H inverted 1IMA, 1IMB [40]
Lipoxygenase-3 yes, H inverted 1IK3a [41]
Cytochrome P-450CAM no 1PHA, 1PHB [42]
Reaction center from no 6PRC, 7PRC [43]
Rodopseudomonas
viridis
In most cases, there are two separate structures for the enantiomers, but in two cases a single crystal structure refined best if the bound
ligand was modeled as a mixture of both enantiomers in the same site. One example [44] is not included in the table because the refinement
gave flat structure for the sp3 stereocenter. However, it appears to be an example mirror-image inversion. Another example [45] was not
included because the coordinates are not available in the protein data bank, but the figures suggest that it is a mirror-image inversion.
a The structure was refined with a mixture of enantiomers in the same site.ent in proteins (Table 4). In all but two of the eighteen s
aexamples a hydrogen adopts a mirror-image orientation
in the two enantiomers. The two exceptions contain a
pquaternary stereocenter, which lacks a hydrogen at the
stereocenter. This survey suggests that a C–H lacks s
Xsignificant interactions with protein binding sites and
enantiomers containing a hydrogen at the stereocenter a
vfavor the mirror-image orientation. Although mirror-
image packing of enantiomers was suggested at least v
p20 years ago [21] and was noted in X-ray structures
recently [38], most modeling and discussions only con- pider exchange of substituents as the orientation of en-
ntiomers.
At first, the two types of experimental data in this
aper—phosphonate X-ray structures and kinetic mea-
urements—appear inconsistent. The phosphonate
-ray structures suggest a poorer fit for the slow en-
ntiomer, but the kinetic constants show a similar KM
alues for both enantiomers, but 100-fold different kcat
alues. One way to resolve this contradiction is to hy-
othesize that the slow enantiomer also binds non-
roductively. This nonproductive binding would not
Mirror-Image Packing in Enantiomer Discrimination
435lead to catalysis or a tetrahedral intermediate and thus
would not be observed in a phosphonate structure that
mimics the tetrahedral intermediate. This nonprod-
uctive binding would contribute to a lower KM since KM
includes both productive and nonproductive binding.
While the nonproductive binding of the slow enanti-
omer can explain how the kinetic parameters match the
X-ray structures, it is not a mechanism of enantiomer
recognition. Nonproductive binding lowers both the ob-
served KM and kcat [22]. The lower KM comes from the
ability of the substrate to bind in another manner; the
lower kcat comes from the blocking of the active site
by this binding. Selectivity is the ratio of kcat and KM;
thus, this lowering of both kinetic constants does not
change selectivity.
Previous lipase-inactivator complexes showed that
enantioselectivity toward secondary alcohols stems
from a missing key hydrogen bond between the alcohol
oxygen and catalytic His N2 for the slow-reacting en-
antiomer [10], which could account for the lower kcat
of the slow-reacting enantiomer. At present, we cannot
exclude either of these explanations for the enantiose-
lectivity and, indeed, both may contribute. Regardless
of the exact mechanism it is clear that enantioselectiv-
ity stems from subtle differences in the orientations of
the two enantiomers.
Given the subtlety of the interactions, it may be diffi-
cult to rationally predict substrate modifications or li-
pase mutations that would increase the enantiose-
lectivity. Indeed, previous substrate modifications to
increase the enantioselectivity of BCL toward primary
alcohols met with only limited success [20].
Differences between the previous modeling and cur-
rent phosphonate structures may in part be due to dif-
ferences in the acyl group. Modeling focused on the
acetyl esters, while the phosphonates used here corre-
spond to the heptanoyl esters. The mechanisms of
enantioselectivity may differ for the acetate and hepta-
noate esters of MPP. Enantioselectivity of the BCL-cat-
alyzed hydrolysis of the MPP acetate is at least 10-fold
less enantioselective that of MPP heptanoate (E = 16
versus >190 [17]). Further, the enantioselectivity toward
MPP acetate stems from differences in KM [8], while
enantioselectivity for MPP heptanoate stems from dif-
ferences in kcat. The X-ray structures of the phospho-
nates show that the heptanoyl group binds in the large
pocket, but the acetyl group would leave this area free,
so that acetate esters of MPP may bind differently.
Significance
Molecular recognition, especially enantiomer recogni-
tion, is pivotal to the understanding of the molecular
action of enantiopure drugs and critical to the design
of new and more efficient synthetic routes to such
drugs. Despite this need, our understanding of en-
antiomer recognition by biological receptors is still
primitive and most of the efforts in drug design and
synthesis design still rest on trial and error. In this
report, we identify the molecular basis for the enan-
tioselectivity of Burkholderia cepacia lipase (BCL)
toward 2-methyl-3-phenyl-1-propanol (MPP), an un-
natural substrate, using X-ray crystal structures oftransition state analogs. These X-ray crystal struc-
tures reveal a mirror-image packing of enantiomers
and only subtle differences between them in spite of
a high enantioselectivity of BCL toward these enanti-
omers. This mirror-image packing allows three sub-
stituents at the stereocenter to bind in nearly the
same position, while the fourth substituent, hydro-
gen, points in opposite directions. A survey of other
structures of enantiomers bound to enzymes indi-
cates this mirror-image packing is the most common
orientation. In contrast, most researchers currently as-
sume that enantiomer recognition involves an ex-
change of substituent positions. This thinking may
stem from mechanical models where interconverting
enantiomers requires exchanging two substituents.
These assumptions about enantiomer recognition may
contribute to the difficulties in understanding enanti-
omer recognition.
Experimental Procedures
All chemicals were purchased from Sigma-Aldrich Co. (Oakville,
ON) unless otherwise specified. Lipase from Burkholderia cepacia
was purchased from Genzyme Diagnostics (Cambridge, MA) under
its older name of Pseudomonas cepacia lipase. 1H NMR spectra
were collected at 270 MHz, 13C NMR at 68 MHz, and 31P NMR at
109 MHz. Protein images were generated using PyMol [23].
(RC, RPSP) Hexylphosphonic Acid 2-Methyl-3-Phenylpropyl
Ester 4-Nitrophenyl Ester, 1-(R)
A solution of (R)-2-methyl-3-phenyl-propan-1-ol (0.17 g, 1.11 mmol)
in dichloromethane (2 ml) was added to a solution of hexylphos-
phonic dichloride (0.21 ml, 1.11 mmol) and di-isopropyl ethyl amine
(0.55 ml, 3.16 mmol) in dichloromethane (9 ml) previously cooled to
5°C with an ice bath. After 1 hr of stirring, 1H-tetrazole (0.07 mg,
0.10 mmol) was added. When the (R)-2-methyl-3-phenyl-propan-
1-ol was consumed (TLC observation, 1.5 hr), the ice bath was re-
moved and an excess of 4-nitrophenol (0.30 g, 2.12 mmol) was
added to the reaction mixture. After 3 hr an excess of di-isopropyl
ethyl amine (0.40 ml, 2.30 mmol) was added. The solution was
stirred overnight at room temperature, then the solvent was evapo-
rated under vacuum. The product was purified by column chroma-
tography over silica gel using hexane/ethyl acetate as eluent, and
concentrated by rotary evaporation to a yellow oil. Yield 22%. Rf =
0.55 (silica gel, 6:4 hexane-ethyl acetate); 1H NMR (CDCl3) δ 8.20
(d, 2H, CH, J = 7.2 Hz), 7.2–7.35 (m, 5H), 7.10 (d, 2H, CH, J = 6.4
Hz), 3.92–3.96 (m, 2H), 2.65–2.75 (m, 1H), 2.39–2.48 (m, 1H), 1.85–
2.20 (m, 3H), 1.24–1.80 (m, 8H), 0.8–0.93 (m, 6H); 13C NMR (CDCl3)
δ 155.5, 139.3, 139.2, 128.6, 128.2, 125.5, 120.8, 70.5, 39.0, 35.9,
31.0, 29.9, 26.2, 25.1, 22.0, 16.2, 13.8; 31P NMR (CDCl3) δ 31.39,
31.37; MS (CI, NH3) m/z (rel. intensity) 420.0 (5, M + H+), 132 (100,
M+ − P(O)(C6H13)(OC6H4NO2)OH), 117 (67, M+ − P(O)(C6H13)(OC6H4-
NO2)OH - CH3), 91 (25, tropylium).
(SC, RPSP) Hexylphosphonic Acid 2-Methyl-3-Phenylpropyl
Ester 4-Nitrophenyl Ester, 1-(S)
The reaction was performed as for 1-(R). Yield 20% (yellow oil). Rf =
0.55 (silica gel, 6:4 hexane-ethyl acetate); NMR and MS are the
same as those for 1-(R).
Inactivation of BCL by 1-(R) and 1-(S)
BCL was dissolved in potassium phosphate buffer (50 mM [pH
7.5]), to a final concentration of 22.5 nM. 1-(R) and 1-(S) were dis-
solved in n-propanol to a final concentration of 32 mM. The BCL
solution (0.25 ml) was mixed with the inactivator solution (0.25 ml)
and incubated at room temperature overnight. The hydrolytic activ-
ity against p-nitrophenol acetate dropped to <2%. The solutions
were dialyzed against water for 24 hr. After dialysis, a white precipi-
tate (BCL-inactivator complex) formed. The suspensions were
centrifuged at 4300 rpm and 4°C, the supernatant was discarded,
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436and the protein was redissolved in a solution of 50% n-propanol
and 50% imidazole buffer (50 mM [pH 6.5]). The complexes were
concentrated using Microcon YM-30® ultrafiltration membranes
(Millipore Corp., Nepean, Ontario, Canada) and the concentrated
protein diluted in the same buffer to a concentration of 10 mg/ml.
Crystallization, Diffraction Data Collection, and Structure
Determination for the Complexes BCL-1-(R ) and BCL-1-(S )
Crystals of the complexes were grown by vapor diffusion. The drop
contained protein (10 mg/ml) in imidazole buffer (50 mM [pH 6.5],
containing 50 vol% n-propanol). The reservoir solution contained
50 mM imidazole buffer (pH 6.5), and 25-30 vol% n-propanol.
Diffraction data were collected at beamline X8C at the National
Synchrotron Light Source, Brookhaven National Laboratory (Upton,
NY) using an ADSC (San Diego, CA) Quantum-4 CCD detector. Dif-
fraction data for complex BCL-1-(R) were collected at a wavelength
of 0.9794 Å in two 180° sweeps. The first sweep was collected with
1° oscillations, 30 s exposures and a crystal to detector distance
of 90 mm. The low-resolution reflections that were overloaded in
the first sweep were re-collected in a second 180° frame sweep
collected at a crystal to detector distance of 140 mm using 4 s
exposures. The BCL-1-(S) data were collected at a wavelength of
0.9795 Å in 180 frames using 1° oscillations, 60 s exposures, and a
distance of 140 mm. Data reduction was performed with DENZO/
SCALEPACK [24].
The three-dimensional model of unliganded BCL (PDB ID 3LIP
[12], ) was placed in the unit cell by rigid body refinement followed
by conjugate gradient minimization and simulated annealing refine-
1ment using CNS [25]. The model was corrected and solvent was
added using 3Fo-2Fc and Fo-Fc difference maps. After conjugate
gradient minimization and restrained individual B-factor refinement
in CNS, the phosphonate inactivator molecules were modeled into
1Fo − Fc difference maps. Final refinements were done using Refmac
5.1.24 [26]. The progress of the refinement was monitored by Rfree,
1which was calculated from a randomly selected portion (5%) of the
diffraction data.
Kinetic Constants for the BCL Catalyzed Hydrolysis
1of (R)- and (S)-2-Methyl-3-Phenyl-1-Propyl Heptanoate
kcat and KM were calculated from kinetic data collected on a
SpectraMAX 340 microplate reader using SoftMax Pro 2.2.1 soft-
1ware (Molecular Devices Corp., Sunnyvale, CA) using a p-nitrophe-
nol pH indicator to monitor ester hydrolysis. Concentrations in
wells were as follows: N,N-bis-(2-hydroxymethyl)-2-aminoethane-
sulfonic acid [BES] = 7.55 mM, p-nitrophenol [PNP] = 1.25 mM,
1[BCL] = 2.85 g/ml or 28.5 g/ml, [(R) and (S)-2-methyl-3-phenyl-
1-propyl heptanoate] = 0.6 to 4.5 mM, [n-propanol] = 27%. Data
were analyzed using Eadie-Hofstee plots [27, 28].
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